A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults
Human Vaccines · 2005
DOI: 10.4161/hv.1.1.1553 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Human Vaccines, 2005. Verfasst von Scott A Halperin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dalhousie University, Halifax, Nova Scotia, Canada. scott.halperin@dal.ca. Die Arbeit wurde bisher 18-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dalhousie University, Halifax, Nova Scotia, Canada. scott.halperin@dal.ca
Zitieren
APA
Halperin, S. A., Smith, B., Clarke, K., Treanor, J., Mabrouk, T., & Germain, M. (2005). A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults. Human Vaccines. https://doi.org/10.4161/hv.1.1.1553
Vancouver
Halperin SA, Smith B, Clarke K, Treanor J, Mabrouk T, Germain M. A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults. Human Vaccines. 2005. doi:10.4161/hv.1.1.1553
BibTeX
@article{Halperin2005,
author = {Halperin, Scott A and Smith, Bruce and Clarke, Kevin and Treanor, John and Mabrouk, Taoufik and Germain, Marc},
title = {A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults},
journal = {Human Vaccines},
year = {2005},
doi = {10.4161/hv.1.1.1553}
}
EUVIMED